Swiss Chemicals Stock News

Romande Energie Holding reported first half 2026 revenue of CHF 407.16 million and net income of CHF 46.4 million, alongside higher electricity and thermal generation volumes compared with the prior year period. Construction of the 10 MW Les Muids wind farm in France adds to Romande Energie Holding's 240 MW gross renewable portfolio across 14 operating assets and several projects under development. The combination of stronger first half profitability and the new Les Muids wind farm under...

UBS Group has delivered a very strong 5 year share price gain, yet current valuation checks still suggest the stock trades at a discount to what its fundamentals might justify. The Excess Returns intrinsic value estimate and market multiple view both lean toward undervaluation, even after this extended run. Over the past 5 years, UBS Group has returned about 226%, which puts pressure on any argument that it remains an obvious bargain without further analysis. Recent moves such as expanding...

Recent earnings event and what changed in the EMS-CHEMIE HOLDING story EMS-CHEMIE HOLDING (SWX:EMSN) just reported half year 2026 results, with sales at CHF 1,010.06 million versus CHF 1,019.59 million a year earlier, while net income reached CHF 258.29 million and earnings per share rose to CHF 11.04. That mix of slightly softer sales and higher profitability provides a clearer view of how the business is managing costs and pricing, which helps frame any assessment of the recent share...

In September 2026, European markets have faced challenges due to rising energy prices and inflation concerns, with the STOXX Europe 600 Index experiencing a decline. Despite these pressures, opportunities may exist for discerning investors seeking undervalued stocks that could potentially benefit from stabilizing conditions and technological advancements.

Novartis has delivered a strong 81.1% gain over the past five years, yet its current valuation checks still lean cheap. That puts fresh pressure on investors to judge whether the recent pullback is an opening or a warning. After a sharp 15.0% decline over the last week and an 11.9% slide over the past month, the stock looks out of step with its longer term track record. Over five years, Novartis has returned 81.1%, which points to meaningful long run value creation despite short term...

Geopolitics is heating up, central banks are keeping rates higher for longer, and UBS is openly warning that investors may be too relaxed about future volatility. That mix is reshaping how wealthy families use global wealth managers and private banks. If you care about where high net worth money goes when risk feels underpriced, you will want to see which 3 stocks in this screener are most exposed to this shift. The three stocks in this article are only a starter sample, since the full screen...

The analysts covering Swiss Life Holding AG ( VTX:SLHN ) delivered a dose of negativity to shareholders today, by...

Medacta Group shares closed at CHF118 after a tough run, with the stock down around 12% over the past three months. The market looks tired. The earnings release tells a different story. H1 2026 revenue reached €368.2m with net income of €41.9m, and management kept full year guidance and mid term targets intact. That combination of pressure on recent returns and reaffirmed growth ambitions is what matters for long term holders who care more about the next five years than the next five...

BioVersys stock closed at CHF27.40 after a choppy few weeks, with the share price down about 3% over seven days despite a slightly positive three month run. Traders reacted to a familiar biotech story, with heavy investment in trials, rising research spend and another half year loss of CHF15.6 million. The near term numbers look bruising. The longer view depends on whether a CHF69.3 million cash pile and an antibiotics and tuberculosis pipeline can carry the business through several more...

Partners Group Holding reported H1 2026 figures on 1 September 2026, with revenue of CHF 1,120.7 million and net income of CHF 502.1 million, both lower than the prior year period, and basic EPS from continuing operations of CHF 19.49. The combination of softer revenue and reduced earnings per share highlights pressure on the fee engine that underpins Partners Group Holding’s private markets platform. We will now look at how Partners Group Holding’s softer half year revenue shapes the...

UBS Group launched nine concurrent tender offers in early September 2026 to repurchase senior notes originally issued by Credit Suisse, while also expanding its U.S. wealth management bench with experienced advisors in key markets like Los Angeles, Atlanta and Bethesda. The bank’s decision to actively manage funding costs through the note buybacks, together with a higher Federal Reserve rate outlook, highlights how UBS is aligning its balance sheet and advisory franchise with a stickier...

EMS-CHEMIE HOLDING reported half-year 2026 results with sales of CHF 1,010.06 million, net income of CHF 258.29 million and basic earnings per share from continuing operations of CHF 11.04. Profit per share rose compared with the prior year while sales were slightly lower, which may point to tighter cost control or a richer product mix supporting stronger profitability. With profitability improving even as sales eased, investors may monitor how this develops within EMS-CHEMIE HOLDING's...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Accelleron Industries reported half-year 2026 results, with sales of US$737.35 million, net income of US$143.88 million, and basic and diluted EPS from continuing operations of US$1.53, all compared with the prior year period. The combination of higher sales and stronger profitability highlights how Accelleron Industries is converting demand into earnings, which can reshape views on the sustainability of its current business momentum. Next comes a look at how Accelleron Industries' stronger...

Central banks are trying to cool inflation without choking off growth, and that tug of war is quietly reshaping where money flows across global infrastructure and industrials. If policy leans more pro growth, capital may chase companies built to benefit from long term investment rather than short term hype. This article unpacks that story and introduces 3 stocks exposed to these policy shifts so you can judge whether they fit your watchlist. The three stocks below are a small sample, and the...

Burkhalter Holding guidance puts earnings trajectory in focus Burkhalter Holding (SWX:BRKN) has reported firmer half-year figures and reaffirmed its outlook for 2026, with management still anticipating a moderate earnings per share increase compared with 2025. Recent trading has been mixed for Burkhalter Holding, with the share price at CHF133.2 after a 1-day gain of 1.83%, a 7-day share price return of 1.52%, but a 90-day share price decline of 17.47%. This contrasts with a 5-year total...

lastminute.com N.V. ( VTX:LMN ), is not the largest company out there, but it received a lot of attention from a...

Record AI related bond issuance, rising long term Treasury yields and an expanding supply of government and corporate debt are reshaping how capital moves through global markets. That mix can unsettle growth stocks, but it can also open fresh angles for investors who follow the bond desks of large investment banks. This article walks through three stocks from our screener that appear especially exposed to this story, and it explains why that may matter for your watchlist. The three stocks...

New Bern Office and Dubai Leadership Shift Put Expansion in Focus EFG International (SWX:EFGN) has set a clear growth tone with two fresh moves: a new office in Bern and a new CEO for its Dubai Advisory Office, both aimed at high-net-worth clients. These expansion moves come at a time when EFG International’s share price has declined 19.64% year to date, while total shareholder return over five years is 186.78%. This points to strong long term value creation despite recent share price...

Banque Cantonale de Genève SA recently reported its half-year 2026 results, with net interest income rising to CHF 183.26 million and net income reaching CHF 118.59 million, both higher than a year earlier. The combination of higher net interest income and stronger net income points to improved profitability in the first half of 2026. We will now examine how this improvement in net income shapes Banque Cantonale de Genève’s broader investment narrative for investors. This technology could...

Half year earnings put Stadler Rail stock in focus Stadler Rail (SWX:SRAIL) is back on investors’ radar after reporting half year 2026 earnings, with sales of CHF 1,965.31 million and net income of CHF 34.39 million from continuing operations. The earnings release appears to have shifted sentiment around Stadler Rail, with the share price at CHF 29.54 and a 30 day share price return of 17.88% and 90 day share price return of 37.40% suggesting momentum has picked up recently. While the 1 year...

Key takeaways from Jungfraubahn Holding’s latest half year earnings Jungfraubahn Holding (SWX:JFN) recently reported half year 2026 earnings, with sales of CHF 15.24 million and revenue of CHF 136.95 million. Net income reached CHF 28.94 million and basic EPS came in at CHF 4.96. Jungfraubahn Holding’s latest half year results, which showed lower sales, revenue and net income than a year ago, have come alongside a recent pick up in the share price, with a 7 day share price return of 4.15% and...

Recent earnings and bond issue put Swiss Life Holding stock in focus Swiss Life Holding (SWX:SLHN) has drawn fresh attention after reporting higher half year net income along with a new €600 million callable Eurobond maturing in 2046, giving investors new information on profitability and funding. Swiss Life Holding shares are trading at CHF938.4 after an 11.93% 90-day share price return, while the 1-year total shareholder return of 17.39% and 5-year total shareholder return of 151.14%...

EPIC Suisse (SWX:EPIC) drew fresh attention on 25 August 2026 after reporting half year 2026 earnings, with higher sales, revenue and net income compared with the same period a year earlier. Despite the stronger half year numbers, EPIC Suisse’s recent share price performance has been more muted. The stock is at CHF83.8 with a 90 day share price return of 1.70%, while the 3 year total shareholder return of 57.22% points to much stronger longer term momentum. Compare EPIC Suisse’s post earnings...